Nir Uriel, MD MSc
@nirurielmd
Cardiologist • Director of Advanced Heart Failure and Transplant @nyphospital • Professor of Medicine @ColumbiaMed @WeillCornell
ID: 951838829945786368
https://www.columbiadoctors.org/nir-uriel-md 12-01-2018 15:30:36
550 Tweet
5,5K Followers
445 Following
Rockstar Dor Lotan, MD presenting primary results from the Ramp It Up 3 study at The ISHLT #ISHLT2025 late breaking clinical science session 💪🏻💪🏻💪🏻 Nir Uriel, MD MSc Gabriel Sayer ColumbiaCardiology
Challenges of heart allocation going from 1A to 1 / 1E? Call to action needed. Continuous distribution model needs optimization before coming into effect. great talk by Rebecca Cogswell NYU Grossman School of Medicine Nir Uriel, MD MSc Randal Goldberg Alex Reyentovich, MD The ISHLT Kiran Khush Manreet Kanwar
🤯 Results from The ISHLT’s relaunching of IMACS, a global MCS registry by Montefiore Health System’s Danny Goldstein, incredible outcomes in Asia/Pacific as compared to US and Europe! #ISHLT2025 JHLT Jennifer Cowger
The formidable Boaz elad presenting findings on the impact of Impella support pre-dVAD on de-novo AI development. Phenomanel job! The ISHLT #ISHLT2025 Nir Uriel, MD MSc Gabriel Sayer ColumbiaCardiology 1/2
Moving 🚚 away from biopsy to non-invasive testing as the 🥇 gold standard after 🫀transplantation. SHORE investigators & CareDx® are moving the 🪡! The ISHLT JHLT #ishlt2025 Kiran Khush Nir Uriel, MD MSc Sean Pinney Stanford Heart Failure, Cardiac Transplant and MCS
It was an honor to present our outcomes for bloodless heart transplantation. With an experienced surgeon and great team, it’s possible to get patients through HT successfully w/ similar outcomes. UChicagoCardio UChicagoHVC Mark Belkin Manreet Kanwar Ben Chung MD Gene Kim
🚨LATE-BREAKING DATA this weekend at #HeartFailure2025. Nir Uriel, MD MSc presented a comparative analysis on 2-year survival outcomes for #HeartMate3 LVAD and HTx patients <50 showing a 12% reduced mortality when measured from time of HM3 implant compared to death or delisting from
Stanford Heart Failure, Cardiac Transplant and MCS's Erik Henricksen & Kiran Khush tackle the ❓of upper limit of age for 🫀transplant from an SRTR analysis. ➡️Stanford Medicine summary: shorturl.at/jVmUf ➡️JHLT: pubmed.ncbi.nlm.nih.gov/39122221/ Eldrin Lewis Sunny Varshney, MD Ronald Witteles Alex Sandhu euan ashley Stanford University
Electrostatic discharge may lead to complete HeartMate 3 pump stoppage—awareness and education can prevent this serious complication Nir Uriel, MD MSc @ersied727 Dor Lotan, MD Ilan Richter @ELadBoaz #AHAJournals ahajrnls.org/4k5jb8h
Everything you want to know about belatacept therapy in heart transplant recipients Our experience now in JHLT ColumbiaCardiology Excellent work from ⭐️ fellow Dr. Julia Baranowska! Gabriel Sayer 📎 jhltonline.org/article/S1053-…
Today, our #HeartMate3 LVAD is a trusted choice for advanced #HeartFailure care. How did we get here? 🔍Explore the data and patient outcomes over the last decade in our webinar with Dr. Ezequiel Molina MD, FACS, FACC and Dr. Nir Uriel, MD MSc: bit.ly/43uKHpS US Safety Info:
Abbott Cardiovascular Ezequiel Molina MD, FACS, FACC Privileged to be part of this Webinar with dear friend Ezequiel Molina MD, FACS, FACC on 10 years of HM3 data Looking forward to more innovation to help our patients!
Molecular microscope in combination with cfDNA diagnosed more rejection than histology - are we on the precipice of new gold standard in rejection detection, learn more in our new paper in JHLT The ISHLT Columbia University HeartSource ColumbiaCardiology jhltonline.org/article/S1053-…
Sex Differences in Utilization of Donation After Circulatory Death Donors for Heart Transplantation and Associated Outcomes Nir Uriel, MD MSc @ersied727 Dharini Ramu Elena Marie Rebecca Cogswell #AHAJournals ahajrnls.org/3I12ugh
Our ColumbiaCardiology experience with letermovir prophy for mod/high risk CMV post-OHT, a promising new therapy to avoid the typical leukopenia seen with valcyte Link to article now in Journal of Cardiac Failure onlinejcf.com/article/S1071-…